Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in LEXX — Lexaria Bioscience Corp.

CIK 1214717 BOSTON, MA
Back to LEXX Full portfolio

Position in LEXX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$140,231
-$89,211 QoQ
Shares Held
16,694
-14.9% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 31 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LEXX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names. LEXX ranks #424 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in LEXX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $140,231 250,415
2026-03-31 $229,442 294,157
2025-12-31 $135,565 219,718
2025-09-30 $166,563 174,779
2025-06-30 $152,057 174,779
2025-03-31 $294,901 172,457
2024-12-31 $350,025 166,679
2024-09-30 $458,692 150,391
2024-06-30 $319,096 114,783
2024-03-31 $360,596 99,338
2023-12-31 $66,990 53,592
2023-09-30 $47,416 47,416
2023-06-30 $35,651 48,837
2023-03-31 $132,836 48,837
2022-12-31 $120,139 48,837
2022-09-30 $120,054 49,002
2022-06-30 $148,779 49,926
2022-03-31 $161,706 49,002
2021-12-31 $197,478 49,002
2021-09-30 $306,752 49,002
2021-06-30 $352,695 50,385